Value-Based Care for Healthy Children With First Episode of Febrile Neutropenia.
| Autor: | Grandjean-Blanchet C; Divisions of Pediatric Emergency Medicine., Le CK; Divisions of Pediatric Emergency Medicine., Villeneuve S; Hematology/Oncology., Cada M; Hematology/Oncology., Beck CE; Pediatric Medicine., Science M; Infectious Diseases, The Hospital for Sick Children, Montreal, Canada., Rosenfield D; Divisions of Pediatric Emergency Medicine., Ostrow O; Divisions of Pediatric Emergency Medicine. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Hospital pediatrics [Hosp Pediatr] 2023 Jun 01; Vol. 13 (6), pp. 536-544. |
| DOI: | 10.1542/hpeds.2022-007075 |
| Abstrakt: | Objectives: There is a lack of guidance on the management of febrile neutropenia in otherwise healthy children, including the need for hospitalization and antibiotic administration, leading to significant practice variation in management. The aim of this initiative was to decrease the number of unnecessary hospitalizations and empirical antibiotics prescribed by 50% over a 24-month period for well-appearing, previously healthy patients older than 6 months presenting to the emergency department with a first episode of febrile neutropenia. Methods: A multidisciplinary team of stakeholders was assembled to develop a multipronged intervention strategy using the Model for Improvement. A guideline for the management of healthy children with febrile neutropenia was created, coupled with education, targeted audit and feedback, and reminders. Statistical control process methods were used to analyze the primary outcome of the percentage of low-risk patients receiving empirical antibiotics and/or hospitalization. Balancing measures included missed serious bacterial infection, emergency department (ED) return visit, and a new hematologic diagnosis. Results: Over the 44-month study period, the mean percentage of low-risk patients hospitalized and/or who received antibiotics decreased from 73.3% to 12.9%. Importantly, there were no missed serious bacterial infections, no new hematologic diagnoses after ED discharge, and only 2 ED return visits within 72 hours without adverse outcomes. Conclusions: A guideline for the standardized management of febrile neutropenia in low-risk patients increases value-based care through reduced hospitalizations and antibiotics. Education, targeted audit and feedback, and reminders supported sustainability of these improvements. (Copyright © 2023 by the American Academy of Pediatrics.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|